Salivary metabolite profiling distinguishes patients with oral cavity squamous cell carcinoma from normal controls.
Oral cavity squamous cell carcinoma (OCC) and oropharyngeal squamous cell carcinoma (OPC) are among the most common cancers worldwide and are associated with high mortality and morbidity. The purpose of this study is to identify potential biomarkers to distinguish OCC/OPC from normal controls and to...
Main Authors: | Pawadee Lohavanichbutr, Yuzheng Zhang, Pei Wang, Haiwei Gu, G A Nagana Gowda, Danijel Djukovic, Matthew F Buas, Daniel Raftery, Chu Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6147497?pdf=render |
Similar Items
-
Distinguishing NASH Histological Severity Using a Multiplatform Metabolomics Approach
by: George N. Ioannou, et al.
Published: (2020-04-01) -
A new limit for blood metabolite analysis using 1H NMR spectroscopy
by: G.A. Nagana Gowda, et al.
Published: (2022-12-01) -
Metabolite Predictors of Breast and Colorectal Cancer Risk in the Women’s Health Initiative
by: Sandi L. Navarro, et al.
Published: (2024-08-01) -
Differentiating Hepatocellular Carcinoma from Hepatitis C Using Metabolite Profiling
by: Siwei Wei, et al.
Published: (2012-10-01) -
Development of a salivary autoantibody biomarker panel for diagnosis of oral cavity squamous cell carcinoma
by: Pei-Chun Hsueh, et al.
Published: (2022-10-01)